Litigation Details for Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2015-06-26
Court	District Court, N.D. West Virginia	Date Terminated	2017-09-12
Cause	35:271 Patent Infringement	Assigned To	Irene Patricia Murphy Keeley
Jury Demand	None	Referred To
Patents	6,551,620; 8,337,886; 8,496,965; 8,865,688
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2016-04-12	117		These include: Patent No. 6,551,620 (“the ‘620 Patent”); Patent No. 8,337,886 (“…the ‘886 Patent”); Patent No. 8,496,965 (“the ‘965 Patent”); and 8,865,688 (“the ‘688 Patent”). The …CONSTRUING PATENT CLAIMS This patent infringement case involves four United States patents issued …‘620, ‘886, and ‘965 Patents, collectively referred to as the Otterbeck patents,1 contain two disputed…dispute one claim term in the ‘688 Patent. The Otterbeck patents cover a controlled	External link to document
2017-04-10	208		Regarding Infringement of United States Patent Number 8,865,688 by Dr. Falk Pharma GmbH, Salix Pharmaceuticals… 12 September 2017 1:15-cv-00109 830 Patent None District Court, N.D. West Virginia	External link to document
2017-05-05	226		Regarding Infringement of United States Patent Number 8,865,688 filed by Dr. Falk Pharma GmbH, Salix Pharmaceuticals… 12 September 2017 1:15-cv-00109 830 Patent None District Court, N.D. West Virginia	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document